UCSF GI DIVISION FACULTY

Mandana Khalili, M.D.

Associate Professor of Clinical Medicine, Director of Clinical Hepatology, SFGH

Address:

GI Clinic, 3D
San Francisco General Hospital
San Francisco, CA 94110

Email:

mandana.khalili@ucsf.edu

Active Projects:

1. Insulin resistance in hepatitis C.
2. HCV-induced alterations in glucose metabolism,
3. Determinants of severity of liver disease in patients with chronic hepatitis C and normal ALT (natural history study).
4. Safety and efficacy of combination antiviral therapy in patients with chronic hepatitits C and genotype 1.
5. Role of new anti-viral therapy or combination therapy in patient with chronic hepatitis B.
6. Antiviral therapy in patients with HIV/HCV coinfection.

Techniques in Use:

1. Utilization of various techniques to measure metabolic abnormalities and insulin resistance in patients with hepatitis C.
2. Epidemiologic and natural history studies.
3. Clinical trials involving existing or new drugs.

Recent Publications:

Khalili M, Vardanian A, Hamerski C, Wang R, Roberts J, Terrault N. Comparison of Clinical Management Of Hepatitis C-Infected Transplant Recipients at Large North-American Transplant Centers: A 5 year comparison. Clinical Transplantation. 2006 Jan-Feb;20(1):1-9.

Khalili M, Fisher E, Bernstein D, Lentz E, Barylski C, Hoffman-Terry M. Peginterferon alfa-2a With or Without Ribavirin in HCV/HIV Coinfected Patients: Partially-Blinded and Randomized Multicenter Trial. Digestive Diseases and Sciences, 2005 June; 50(6):1148-55.